HARBIN, China, Oct. 25, 2011 /PRNewswire-Asia/ -- China Botanic Pharmaceutical Inc. (NYSE AMEX: CBP) ("China Botanic" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM") in China, today announced that the Company has recently hosted a technical exchange between 13 senior research specialists in the field of Traditional Chinese Medicine (TCM) and herbal medicine.
China Botanic participated in the technical exchange with leading research specialists of the TCM industry at the Company's headquarters to review the Company's scientific endeavors. The technical exchange gathering included Mr. Jisheng Chen, a noted medical scholar from the China Academy of Engineering, Mr. Zhengwu Qi, an acclaimed researcher from the China Academy of Sciences, and other well-known scientists and professors specializing in bio-pharmaceutical biological research from China's leading universities and research institutes. Mr. Chen is a pharmaceutical chemist and is renowned for his knowledge of natural medicine chemistry and drug design. Mr. Qi is also a well-known biochemist and a leader in protein and peptide research.
The leading research specialists recognized the Company's noteworthy achievements in creating effective, plant-based medicines and offered recommendations for further advances. The Company also received suggestions on institutes which may potentially collaborate with China Botanic in researching all-natural plant-based remedies.
"We thank all our distinguished guests for their positive feedback and appreciation of our Siberian Ginseng series and other products," commented Mr. Shaoming Li, Chairman and Chief Executive Officer of China Botanic. "We believe the technical exchange was a great success and China Botanic's research team benefited from the opportunity to discuss ideas with industry leading experts. The positive review of our products further strengthens our commitment towards becoming a leading global provider of all-natural and plant-based medicines."
ABOUT CHINA BOTANIC PHARMACEUTICAL INC.
China Botanic Pharmaceutical Inc. is engaged in the research, development, manufacturing, and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines ("TCM"), in the People's Republic of China. All of the Company's products are produced at its three GMP-certified production facilities in Ah City, Dongfanghong and Qingyang. The Company distributes its botanical anti-depression and nerve-regulation products, biopharmaceutical products, and botanical antibiotic and OTC TCMs through its network of over 3,000 distributors and over 70 sales centers across 24 provinces in China. For more information, please visit www.renhuang.com.